Top 100 Contractors in PSC 6505: Drugs and Biologicals, FY2023

Parent companies by net contract obligations Oct 1, 2022 – Sep 30, 2023 Code page on GovTribe

The top 10 won 95% of FY2023 PSC 6505 contract dollars

Ranking facts

Contract obligations
$17,678,295,372 Net of deobligations, by contracts coded PSC 6505
Contractors
479 Parent companies with an obligation
Largest contractor
Mckesson Corporation $10.1 billion, 56.2% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $10,108,540,298
Rank history: #2 in FY2021, #2 in FY2022, #1 in FY2024 and #1 in FY2025; up 1 since FY2022.
2
Amerisourcebergen Corporation 2 awardees, including Amerisourcebergen Drug Corp
$2,214,293,707
Rank history: not on the FY2021 list, #8 in FY2022, #3 in FY2024 and not on the FY2025 list; up 6 since FY2022.
3 $2,105,169,799
Rank history: #5 in FY2021, #6 in FY2022, #2 in FY2024 and #2 in FY2025; up 3 since FY2022.
4 $1,871,732,633
Rank history: #1 in FY2021, #1 in FY2022, not on the FY2024 list and #61 in FY2025; down 3 since FY2022.
5 $246,928,559
Rank history: #10 in FY2021, #10 in FY2022, #5 in FY2024 and #3 in FY2025; up 5 since FY2022.
6 $149,687,834
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #53 in FY2025; new.
7 $139,028,158
Rank history: #16 in FY2021, #16 in FY2022 and not on the FY2024–FY2025 lists; up 9 since FY2022.
8 $125,526,228
Rank history: #13 in FY2021, #9 in FY2022, #6 in FY2024 and #5 in FY2025; up 1 since FY2022.
9 $85,519,000
Rank history: #20 in FY2021, #18 in FY2022, #9 in FY2024 and #8 in FY2025; up 9 since FY2022.
10 $45,087,231
Rank history: #21 in FY2021, #23 in FY2022, #20 in FY2024 and #28 in FY2025; up 13 since FY2022.
11 $36,398,440
Rank history: #26 in FY2021, not on the FY2022 list, #26 in FY2024 and #44 in FY2025; returned.
12
Teva Pharmaceutical Industries Ltd. Through Teva Pharmaceuticals Usa, Inc.
$36,142,176
Rank history: #22 in FY2021, #24 in FY2022, #40 in FY2024 and not on the FY2025 list; up 12 since FY2022.
13 $34,582,898
Rank history: #31 in FY2021, #27 in FY2022, #17 in FY2024 and #17 in FY2025; up 14 since FY2022.
14 $33,019,488
Rank history: #7 in FY2021, #7 in FY2022 and not on the FY2024–FY2025 lists; down 7 since FY2022.
15 $27,834,264
Rank history: #54 in FY2021, #45 in FY2022, #51 in FY2024 and not on the FY2025 list; up 30 since FY2022.
16 $27,283,173
Rank history: not on the FY2021 list, #14 in FY2022, not on the FY2024 list and #12 in FY2025; down 2 since FY2022.
17 $25,913,218
Rank history: not on the FY2021 list, #38 in FY2022, #19 in FY2024 and #16 in FY2025; up 21 since FY2022.
18 $21,853,475
Rank history: #45 in FY2021, #48 in FY2022, #24 in FY2024 and not on the FY2025 list; up 30 since FY2022.
19 $15,342,941
Rank history: #28 in FY2021, #30 in FY2022, #29 in FY2024 and not on the FY2025 list; up 11 since FY2022.
20 $13,725,415
Rank history: #41 in FY2021, #33 in FY2022, #28 in FY2024 and #22 in FY2025; up 13 since FY2022.
21 $13,270,926
Rank history: #38 in FY2021, #46 in FY2022, #39 in FY2024 and not on the FY2025 list; up 25 since FY2022.
22 $12,341,919
Rank history: #64 in FY2021, #82 in FY2022, #42 in FY2024 and not on the FY2025 list; up 60 since FY2022.
23 $11,813,911
Rank history: #14 in FY2021, #15 in FY2022 and not on the FY2024–FY2025 lists; down 8 since FY2022.
24
Boehringer Ingelheim Corporation Through Boehringer Ingelheim Animal Health France
$11,200,000
Rank history: #32 in FY2021, #32 in FY2022 and not on the FY2024–FY2025 lists; up 8 since FY2022.
25 $10,613,540
Rank history: #68 in FY2021, #74 in FY2022 and not on the FY2024–FY2025 lists; up 49 since FY2022.
26 $10,556,689
Rank history: #42 in FY2021, #47 in FY2022, #41 in FY2024 and #46 in FY2025; up 21 since FY2022.
27 $10,007,004
Rank history: #18 in FY2021, #28 in FY2022, #22 in FY2024 and not on the FY2025 list; up 1 since FY2022.
28 $9,484,067
Rank history: #36 in FY2021, #34 in FY2022 and not on the FY2024–FY2025 lists; up 6 since FY2022.
29 $9,247,278
Rank history: #94 in FY2021, #42 in FY2022, #36 in FY2024 and not on the FY2025 list; up 13 since FY2022.
30
Dakco Distributors Inc. Through Dakota Drug, Inc.
$8,279,463
Rank history: #40 in FY2021, #41 in FY2022, #35 in FY2024 and not on the FY2025 list; up 11 since FY2022.
31 $7,454,492
Rank history: #51 in FY2021, #71 in FY2022, #49 in FY2024 and not on the FY2025 list; up 40 since FY2022.
32 $7,340,444
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
33 $6,284,304
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #26 in FY2025; new.
34
Selux Diagnostics Inc.
$5,676,127
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
35 $5,657,177
Rank history: not on the FY2021–FY2022 lists, #13 in FY2024 and #25 in FY2025; up 146 since FY2022.
36 $5,548,113
Rank history: not on the FY2021–FY2022 lists, #37 in FY2024 and #37 in FY2025; up 77 since FY2022.
37 $5,510,426
Rank history: not on the FY2021 list, #35 in FY2022, #34 in FY2024 and not on the FY2025 list; down 2 since FY2022.
38 $5,490,365
Rank history: #56 in FY2021, #49 in FY2022, #50 in FY2024 and #57 in FY2025; up 11 since FY2022.
39 $4,929,707
Rank history: #71 in FY2021, #85 in FY2022, #46 in FY2024 and #41 in FY2025; up 46 since FY2022.
40 $4,840,105
Rank history: #58 in FY2021, #55 in FY2022, #47 in FY2024 and #39 in FY2025; up 15 since FY2022.
41 $4,832,887
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
42 $4,524,020
Rank history: #50 in FY2021, #63 in FY2022, #48 in FY2024 and not on the FY2025 list; up 21 since FY2022.
43
Heyltex Corporation
$4,142,331
Rank history: not on the FY2021–FY2022 lists, #95 in FY2024 and not on the FY2025 list; new.
44 $3,966,776
Rank history: #86 in FY2021, #65 in FY2022, #83 in FY2024 and #56 in FY2025; up 21 since FY2022.
45 $3,791,923
Rank history: #8 in FY2021, #5 in FY2022, #11 in FY2024 and #18 in FY2025; down 40 since FY2022.
46 $3,532,484
Rank history: #76 in FY2021, #64 in FY2022, #54 in FY2024 and #59 in FY2025; up 18 since FY2022.
47 $3,446,973
Rank history: #37 in FY2021, #51 in FY2022, #53 in FY2024 and #72 in FY2025; up 4 since FY2022.
48 $3,377,218
Rank history: not on the FY2021 list, #72 in FY2022, #99 in FY2024 and not on the FY2025 list; up 24 since FY2022.
49 $3,087,500
Rank history: #61 in FY2021, #99 in FY2022, not on the FY2024 list and #54 in FY2025; up 50 since FY2022.
50 $2,757,100
Rank history: #57 in FY2021, #60 in FY2022, #52 in FY2024 and #47 in FY2025; up 10 since FY2022.
51 $2,539,040
Rank history: #48 in FY2021, #52 in FY2022, #81 in FY2024 and #83 in FY2025; up 1 since FY2022.
52 $2,380,172
Rank history: #84 in FY2021, #68 in FY2022, #58 in FY2024 and not on the FY2025 list; up 16 since FY2022.
53 $2,104,640
Rank history: not on the FY2021–FY2022 lists, #65 in FY2024 and not on the FY2025 list; up 66 since FY2022.
54 $2,093,275
Rank history: #69 in FY2021, #57 in FY2022 and not on the FY2024–FY2025 lists; up 3 since FY2022.
55 $2,026,789
Rank history: #80 in FY2021, #80 in FY2022, #71 in FY2024 and #84 in FY2025; up 25 since FY2022.
56 $1,948,088
Rank history: not on the FY2021 list, #96 in FY2022 and not on the FY2024–FY2025 lists; up 40 since FY2022.
57 $1,947,803
Rank history: #49 in FY2021, #77 in FY2022, not on the FY2024 list and #70 in FY2025; up 20 since FY2022.
58 $1,909,899
Rank history: #11 in FY2021, #75 in FY2022 and not on the FY2024–FY2025 lists; up 17 since FY2022.
59 $1,873,285
Rank history: #66 in FY2021, #81 in FY2022, #75 in FY2024 and #88 in FY2025; up 22 since FY2022.
60 $1,833,706
Rank history: #74 in FY2021, not on the FY2022 list, #89 in FY2024 and not on the FY2025 list; up 79 since FY2022.
61 $1,819,112
Rank history: #72 in FY2021, #70 in FY2022, #84 in FY2024 and #71 in FY2025; up 9 since FY2022.
62 $1,797,040
Rank history: #63 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 329 since FY2022.
63 $1,781,510
Rank history: #98 in FY2021, #93 in FY2022, #70 in FY2024 and not on the FY2025 list; up 30 since FY2022.
64 $1,703,454
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #13 in FY2025; up 250 since FY2022.
65 $1,684,170
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
66 $1,666,806
Rank history: #79 in FY2021, not on the FY2022 list, #73 in FY2024 and not on the FY2025 list; up 41 since FY2022.
67 $1,649,464
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #86 in FY2025; new.
68
Grifols SA Through Gen-Probe Incorporated
$1,634,150
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
69 $1,518,623
Rank history: #27 in FY2021, #31 in FY2022, not on the FY2024 list and #68 in FY2025; down 38 since FY2022.
70 $1,497,673
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
71 $1,484,529
Rank history: #73 in FY2021, #95 in FY2022, #91 in FY2024 and #45 in FY2025; up 24 since FY2022.
72 $1,467,902
Rank history: #88 in FY2021, #84 in FY2022, not on the FY2024 list and #76 in FY2025; up 12 since FY2022.
73 $1,414,899
Rank history: not on the FY2021 list, #78 in FY2022, #88 in FY2024 and #77 in FY2025; up 5 since FY2022.
74 $1,413,267
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 40 since FY2022.
75
Owens & Minor Inc. Through O&M Halyard, Inc.
$1,311,449
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
76 $1,146,771
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #80 in FY2025; new.
77 $1,142,305
Rank history: #97 in FY2021, #90 in FY2022, #67 in FY2024 and not on the FY2025 list; up 13 since FY2022.
78 $1,133,011
Rank history: #82 in FY2021, #89 in FY2022, #96 in FY2024 and not on the FY2025 list; up 11 since FY2022.
79
Jazz Pharmaceuticals Inc.
$1,119,755
Rank history: not on the FY2021–FY2022 lists, #68 in FY2024 and #64 in FY2025; up 44 since FY2022.
80 $1,098,357
Rank history: not on the FY2021–FY2022 lists, #92 in FY2024 and not on the FY2025 list; new.
81 $1,060,237
Rank history: not on the FY2021 list, #88 in FY2022, #77 in FY2024 and not on the FY2025 list; up 7 since FY2022.
82 $1,024,202
Rank history: not on the FY2021–FY2022 lists, #78 in FY2024 and not on the FY2025 list; up 52 since FY2022.
83 $996,223
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 48 since FY2022.
84 $994,264
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
85 $966,885
Rank history: #90 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 128 since FY2022.
86 $947,212
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 76 since FY2022.
87 $940,116
Rank history: #91 in FY2021, #69 in FY2022 and not on the FY2024–FY2025 lists; down 18 since FY2022.
88
AHS Hillcrest Medical Center LLC Through Topeka Hospital, LLC
$917,191
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 16 since FY2022.
89 $900,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
90 $875,200
Rank history: not on the FY2021–FY2022 lists, #56 in FY2024 and #55 in FY2025; up 46 since FY2022.
91 $873,400
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
92 $871,735
Rank history: not on the FY2021 list, #98 in FY2022 and not on the FY2024–FY2025 lists; up 6 since FY2022.
93 $800,857
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
94
Grifols Diagnostic Solutions Inc. 2 awardees, including Grifols USA LLC
$785,573
Rank history: #77 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 60 since FY2022.
95 $753,934
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
96 $751,368
Rank history: #52 in FY2021, #59 in FY2022, #66 in FY2024 and not on the FY2025 list; down 37 since FY2022.
97 $745,975
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 5 since FY2022.
98 $737,127
Rank history: #62 in FY2021, #86 in FY2022, #64 in FY2024 and not on the FY2025 list; down 12 since FY2022.
99 $724,960
Rank history: not on the FY2021 list, #11 in FY2022, not on the FY2024 list and #7 in FY2025; down 88 since FY2022.
100 $714,605
Rank history: not on the FY2021–FY2022 lists, #97 in FY2024 and not on the FY2025 list; up 44 since FY2022.
Show 75 more

100 of 479 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $18 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2023 ran Oct 1, 2022 – Sep 30, 2023. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2022. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2022 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC 6505 contractors in FY2023?

1. Mckesson Corporation ($10.1B), 2. Amerisourcebergen Corporation ($2.21B), 3. Cencora, Inc. ($2.11B), 4. Pfizer Inc. ($1.87B), 5. DMS Pharmaceutical Group Inc. ($247M), 6. Honeywell International Inc. ($150M), 7. Emergent Biosolutions Inc. ($139M), 8. Bavarian Nordic A / S ($126M), 9. Government of the United States ($85.5M), 10. Seqirus USA Inc. ($45.1M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work